Newsletters

11.20.19

Georgia Releases Section 1332 and 1115 Waivers

On November 4, Georgia released two draft waiver applications for public comment—a Section 1332 State Relief and Empowerment Waiver (“1332 waiver”) to restructure the state’s individual insurance market and a Section 1115 waiver, “Georgia Pathways to Coverage,” ...


11.19.19

Preparing for the ONC/HHS Information Blocking Rule

Earlier this year, the federal Office of the National Coordinator for Health Information Technology (ONC) and the Department of Health and Human Services (HHS) issued proposed rules implementing the information blocking prohibition in the 21st Century Cures Act.


11.19.19

Understanding Mental Health Parity: Insurer Compliance and Recent Litigation

The Mental Health Parity and Addiction Equity Act (MHPAEA) requires health plans to provide comparable levels of treatment for mental health conditions and substance use disorders (SUDs) as they do for physical illnesses.


11.19.19

Commercial Co-Ventures/Cause Marketing: A Guide for Healthcare Organizations

Opportunities to sponsor events and partner with other brands can be powerful tools for building awareness, expanding reach, and offering fresh content and experiences that capture new audiences and re-engage existing ones.


11.19.19

CMS Continues 340B Drug Reimbursement Reductions Despite Ongoing Litigation

In the 2018 Hospital Outpatient Prospective Payment System (HOPPS) final rule, CMS finalized a policy to reduce payment for separately payable outpatient drugs purchased by certain hospitals under the 340B program from Average Sales Price (ASP) plus 6% to ASP minus 22.5%.


11.19.19

New Webinar: Understanding the Interplay Between Medicaid and 340B

The 340B drug discount program—which requires drug manufacturers to provide outpatient drugs to eligible healthcare entities at sharply reduced prices—continues to expand, with the number of participating covered entities almost doubling in the past five years to 38,000, according to ...


11.19.19

Promotional Review Best Practices: Mitigating Risks, Maximizing Success

The promotional review process requires a critical balance between ensuring materials achieve business goals and complying with regulatory constraints.


11.19.19

One Step Forward, Two Steps Back: Utah’s Medicaid Expansion

In a new post for The Commonwealth Fund’s To the Point blog, summarized below, Manatt Health examines Utah’s efforts to pair Medicaid expansion in the state with enrollment caps that are set based on the state’s budget.


11.19.19

Now On Demand—Fraud and Abuse Trends: Critical Issues for Health Plans

In FY 2018, the federal government won or negotiated more than $2.3 billion in healthcare fraud judgments and settlements.


11.19.19

Now On Demand—Digital Health: Disruptive Technology or Just a Disruption?

Digital technology is redefining every segment of healthcare—from drug discovery and clinical trials to patient treatment and monitoring.